학술논문
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): A phase 3, double-blind, randomised, placebo-controlled trial
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, 2015, 16(4):447-456)
Subject
Language
English
ISSN
14745488
14702045
14702045